Rheumatology

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending October 29, 2021.

Considerations for the role of telemedicine in caring for patients with SARDs, with deference to the challenges of an accurate patient evaluation.

Cassandra Calabrese, DO, examines immunopathogenesis, immunomodulation, COVID-19 vaccinations, and pre-exposure prophylaxis.

Experts take a dive into available therapies and optimal treatment strategies for idiopathic inflammatory myopathies.

Investigators called for the development of health care system structures to better support the exchanging of resources and information.

“Systemic lupus erythematosus is a chronic inflammatory autoimmune disease where a variety of organ complications contribute to an increased risk of premature mortality,” investigators stated.

Interview questions focused on mental and physical health, guidance received by healthcare providers, and the impact of COVID-19 on healthcare access and self-management behaviors.

“Using the strengthening exercises with mHealth may have the potential to reduce pain, improve mobility, functional activity, and activities of daily living among knee osteoarthritis patients who are overweight or obese," investigators stated.

Data show no significant improvement in pain, function and alignment scores over 26 weeks in the PRP injection group, compared to placebo.

Chronic back pain, a common symptom of axial spondyloarthritis that increases disease burden and reduces quality of life, may be improved by subcutaneous injection of secukinumab 150 mg or 300 mg.

On this month's episode of Overdrive, E Michael Lewiecki, MD, discusses recent controversies and trends in osteoporosis management, predictions for 2022, and how COVID-19 impacted the treatment landscape for rheumatologists.

The risk of adverse outcomes increased the most in pregnancies with antirheumatic treatment, especially those treated with biologic disease modifying antirheumatic drugs (bDMARDs), when compared with controls.

The rates of adverse events was similar across all 4 indications in comparison to the placebo group.

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending October 22, 2021.

A regular fitness routine was associated with less pain and stiffness, as well as an increase in functional capacity, in patients with knee osteoarthritis.

Theresa Human, PharmD, discusses RediTrex, a subcutaneous injection method of administering methotrexate.

Comprehensive insight on the treatment armamentarium for systemic lupus erythematous and nuances in selecting optimal therapy.

A brief review of idiopathic inflammatory myopathies, ranging from pathology to the goals of treatment.

The study examines the impact of antirheumatic treatment on pregnancy outcomes in women with psoriatic arthritis.

A significant number of patients with psoriatic arthritis fail to achieve adequate disease control, resulting in health-related quality of life (HRQOL) impairments.

Dactylitis, a uniform swelling of an entire digit, occurs in up to half of patients with psoriatic arthritis and is sometimes the first manifestation of the condition.

Osteoporosis is a common comorbidity for patients with rheumatoid arthritis. How much do you know about how drugs impact bone health in rheumatoid arthritis?

Jeffrey Stark, MD, discusses the recent studies, BE BRIGHT, BE SURE, and BE VIVID, in which investigators analyzed the impact bimekizumab had on patients with psoriasis.

“Evidence has accumulated on the effectiveness of physical activity to reduce disease-related symptoms such as pain and comorbidity risk in people with rheumatoid arthritis,” investigators stated.

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending October 15, 2021.

During this video interview, Dr. Jay Mehta talks about his approach to explaining such complex medical conditions and treatments to his pediatric patients and their families.

Approximately a third of systemic lupus erythematosus patients experience ocular involvement, which may be linked to disease pathophysiology.

An overview of systemic lupus erythematous including possible causes, prevalence, symptomology, diagnosis, and the goals of therapy.

Expert rheumatologists share an overview of the characteristics of SARDs, covering rare disease status, quality of life, and associated comorbidities.

Investigators analyzed the potential beneficial effect of hydroxychloroquine to prevent COVID-19 infection in patients with rheumatic disease.